Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Debt / NOTE 4.500% 7/1
-
Number of holders
-
24
-
Total principal
-
108M
-
Principal change
-
+720K
-
Total reported value, excl. options
-
$110M
-
Value change
-
+$320K
-
Number of buys
-
15
-
Number of sells
-
-11
-
Price
-
$1.01
Significant Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q1 2014
23 filings reported holding 590328AA8 - MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q1 2014.
MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 has 24 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $108M of principal
.
Largest 10 bondholders include Citadel Advisors LLC ($20M of principal), ARISTEIA CAPITAL LLC ($13.3M of principal), WOLVERINE ASSET MANAGEMENT LLC ($12.4M of principal), LAZARD ASSET MANAGEMENT LLC ($11M of principal), AVIVA PLC ($8.3M of principal), UBS OCONNOR LLC ($7.5M of principal), PUTNAM INVESTMENTS LLC ($5M of principal), JPMORGAN CHASE & CO ($5M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($4.53M of principal), and SILVERBACK ASSET MANAGEMENT LLC ($4M of principal).
This table shows the top 24 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.